Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Fusion Antibodies (LSE:FAB) Rises 7.14% as Patent Progress and Antibody Platform Momentum Strengthen Outlook

Fusion Antibodies shares rose by 7.14% as investors reassessed the value of its intellectual property and improving commercial pipeline. The recent acceptance of an Australian patent application supports the company’s strategy of building international protection around its antibody-library technology.

Ankur Sharma | 26 August 2026

Oxford Nanopore Technologies (LSE:ONT) Rallies 9.78% as Margin Progress and Leadership Appointments Revive Growth Optimism

Oxford Nanopore Technologies shares rose by 9.78% as investors responded to improved financial execution and the strengthening of the company’s leadership team.

Ankur Sharma | 26 August 2026

ProBiotix Health (LSE:PBX) Surges 16.02% as Record Growth and Profitability Spark Investor Optimism

ProBiotix Health shares rose by 16.02% as the market reassessed the company’sEarningspotential following a strong interim update. TheBusinessdelivered record revenue, improved gross profitability and moved from an underlying operating loss into profit. This combination suggests that commercial expansion is beginning to produce operating leverage.

Ankur Sharma | 26 August 2026

Sareum Holdings (LSE:SAR) Surges 27.59% as Clinical Progress Fuels Bullish Momentum

Sareum Holdings plc is a clinical-stage biotechnology company developing small-molecule kinase inhibitors for autoimmune diseases and cancer. Its lead programme, SDC-1801, targets TYK2 and JAK1, signalling pathways associated with inflammation and immune-system activity. The share-price advance reflects renewed confidence in the programme’s development prospects, …

Ankur Sharma | 26 August 2026

Cambridge Nutritional Sciences Surges 9.47% as Diagnostic Testing Demand Revives Investor Optimism

Cambridge Nutritional Sciences PLC (LSE:CNSL) develops and manufactures diagnostic test kits used to assess food intolerance and related immune conditions, supplying practitioners, clinics and consumers through distribution partnerships in multiple markets. The recent share-price rise appears to reflect renewed investor appreciation of continued demand …

Ankur Sharma | 25 August 2026

Why Did AstraZeneca PLC LSE:AZN Edge Higher 0.61% Amid a firmer tone across UK-listed pharmaceutical shares?

AstraZeneca PLC — LSE:AZN rose0.61% on 25 August 2026, taking the shares to 12,184.00p.

Ishan Mudgal | 25 August 2026

Why Did Hemogenyx Pharmaceuticals plc LSE:HEMO Slide 5.34% Amid a softer tone across UK-listed clinical-stage biotechnology shares?

Hemogenyx Pharmaceuticals plc — LSE:HEMO fell5.34% on 25 August 2026, taking the shares to 549.00p.

Ishan Mudgal | 25 August 2026

Why Did Ondine Biomedical Inc. LSE:OBI Slide 4.40% Amid a softer tone across UK-listed life sciences shares?

Ondine Biomedical Inc. — LSE:OBI fell4.40% on 25 August 2026, taking the shares to 11.71p.

Ishan Mudgal | 25 August 2026

Why Did Oxford Nanopore Technologies plc LSE:ONT Edge Higher 0.54% Amid a firmer tone across UK-listed life sciences shares?

Oxford Nanopore Technologies plc — LSE:ONT rose0.54% on 25 August 2026, taking the shares to 167.60p.

Ishan Mudgal | 25 August 2026

LSE:FUM Stock Jumps 16.34%: Eroxon Intense and WSD4000 Create Fresh Investor Interest

Futura Medical PLC has become one of the notable healthcare stocks attracting attention on 25 August 2026, with LSE:FUM rising 16.34%.

Ankur Sharma | 25 August 2026
Support

Hi! How can we help you today?

Loading…